NCT05265910View on ClinicalTrials.gov

A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

December 14, 2021

Primary Completion Date

April 23, 2022

Study Completion Date

April 23, 2022

Conditions
Allergic Conjunctivitis
Interventions
DRUG

olopatadine hydrochloride ophthalmic solution 0.7%

Pataday® Once Daily Relief Extra Strength (eyedrop)

DRUG

loratadine 10 mg

Claritin® Tablets 24-Hour (tablet)

DRUG

Tears Naturale

Tears Naturale® II (eyedrop)

DRUG

Placebo

Placebo tablet (tablet)

Trial Locations (1)

01810

Andover Eye Associates, Andover

Sponsors
All Listed Sponsors
lead

Andover Research Eye Institute

INDUSTRY